vs

Side-by-side financial comparison of Alcoa Corp (AA) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.4B, roughly 1.3× Alcoa Corp). Emerson Electric runs the higher net margin — 13.9% vs 6.2%, a 7.7% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs -1.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $294.0M). Over the past eight quarters, Alcoa Corp's revenue compounded faster (15.2% CAGR vs -0.3%).

Alcoa Corporation is an American industrial corporation that produces aluminum. According to industry rankings, it is among the largest producers globally. The company operates in 10 countries and is involved in mining, refining, smelting, fabricating, and recycling aluminum products.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

AA vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.3× larger
EMR
$4.3B
$3.4B
AA
Growing faster (revenue YoY)
EMR
EMR
+5.2% gap
EMR
4.1%
-1.1%
AA
Higher net margin
EMR
EMR
7.7% more per $
EMR
13.9%
6.2%
AA
More free cash flow
EMR
EMR
$308.0M more FCF
EMR
$602.0M
$294.0M
AA
Faster 2-yr revenue CAGR
AA
AA
Annualised
AA
15.2%
-0.3%
EMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AA
AA
EMR
EMR
Revenue
$3.4B
$4.3B
Net Profit
$213.0M
$605.0M
Gross Margin
53.2%
Operating Margin
2.0%
17.8%
Net Margin
6.2%
13.9%
Revenue YoY
-1.1%
4.1%
Net Profit YoY
5.4%
3.4%
EPS (diluted)
$0.80
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AA
AA
EMR
EMR
Q4 25
$3.4B
$4.3B
Q3 25
$3.0B
$4.9B
Q2 25
$3.0B
$4.6B
Q1 25
$3.4B
$4.4B
Q4 24
$3.5B
$4.2B
Q3 24
$2.9B
$4.6B
Q2 24
$2.9B
$4.4B
Q1 24
$2.6B
$4.4B
Net Profit
AA
AA
EMR
EMR
Q4 25
$213.0M
$605.0M
Q3 25
$232.0M
$637.0M
Q2 25
$164.0M
$586.0M
Q1 25
$548.0M
$485.0M
Q4 24
$202.0M
$585.0M
Q3 24
$90.0M
$996.0M
Q2 24
$20.0M
$329.0M
Q1 24
$-252.0M
$501.0M
Gross Margin
AA
AA
EMR
EMR
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Q1 24
52.2%
Operating Margin
AA
AA
EMR
EMR
Q4 25
2.0%
17.8%
Q3 25
5.6%
16.4%
Q2 25
5.3%
16.1%
Q1 25
19.8%
14.2%
Q4 24
9.7%
18.6%
Q3 24
6.3%
14.7%
Q2 24
3.2%
10.4%
Q1 24
-12.5%
16.2%
Net Margin
AA
AA
EMR
EMR
Q4 25
6.2%
13.9%
Q3 25
7.7%
13.1%
Q2 25
5.4%
12.9%
Q1 25
16.3%
10.9%
Q4 24
5.8%
14.0%
Q3 24
3.1%
21.6%
Q2 24
0.7%
7.5%
Q1 24
-9.7%
11.4%
EPS (diluted)
AA
AA
EMR
EMR
Q4 25
$0.80
$1.07
Q3 25
$0.88
$1.12
Q2 25
$0.62
$1.04
Q1 25
$2.07
$0.86
Q4 24
$1.18
$1.02
Q3 24
$0.38
$1.74
Q2 24
$0.11
$0.57
Q1 24
$-1.41
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AA
AA
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$1.6B
Total DebtLower is stronger
$2.4B
$7.6B
Stockholders' EquityBook value
$6.1B
$20.3B
Total Assets
$16.1B
$41.9B
Debt / EquityLower = less leverage
0.40×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AA
AA
EMR
EMR
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.2B
Q4 24
$1.1B
Q3 24
$1.3B
Q2 24
$1.4B
Q1 24
$1.4B
Total Debt
AA
AA
EMR
EMR
Q4 25
$2.4B
$7.6B
Q3 25
$2.6B
$8.9B
Q2 25
$2.6B
$8.3B
Q1 25
$2.6B
$8.2B
Q4 24
$2.5B
$6.6B
Q3 24
$2.5B
$7.7B
Q2 24
$2.5B
$7.1B
Q1 24
$2.5B
$7.6B
Stockholders' Equity
AA
AA
EMR
EMR
Q4 25
$6.1B
$20.3B
Q3 25
$6.3B
$20.3B
Q2 25
$6.1B
$19.9B
Q1 25
$5.8B
$19.2B
Q4 24
$5.2B
$20.5B
Q3 24
$5.3B
$21.6B
Q2 24
$3.9B
$20.8B
Q1 24
$4.0B
$20.9B
Total Assets
AA
AA
EMR
EMR
Q4 25
$16.1B
$41.9B
Q3 25
$16.0B
$42.0B
Q2 25
$15.0B
$42.5B
Q1 25
$14.6B
$42.0B
Q4 24
$14.1B
$42.6B
Q3 24
$14.5B
$44.2B
Q2 24
$14.3B
$45.6B
Q1 24
$14.3B
$46.4B
Debt / Equity
AA
AA
EMR
EMR
Q4 25
0.40×
0.37×
Q3 25
0.41×
0.44×
Q2 25
0.42×
0.42×
Q1 25
0.44×
0.42×
Q4 24
0.48×
0.32×
Q3 24
0.47×
0.36×
Q2 24
0.63×
0.34×
Q1 24
0.62×
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AA
AA
EMR
EMR
Operating Cash FlowLast quarter
$537.0M
$699.0M
Free Cash FlowOCF − Capex
$294.0M
$602.0M
FCF MarginFCF / Revenue
8.5%
13.9%
Capex IntensityCapex / Revenue
7.0%
2.2%
Cash ConversionOCF / Net Profit
2.52×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$567.0M
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AA
AA
EMR
EMR
Q4 25
$537.0M
$699.0M
Q3 25
$85.0M
$3.1B
Q2 25
$488.0M
$1.1B
Q1 25
$75.0M
$241.0M
Q4 24
$415.0M
$777.0M
Q3 24
$143.0M
$3.3B
Q2 24
$287.0M
$1.1B
Q1 24
$-223.0M
$743.0M
Free Cash Flow
AA
AA
EMR
EMR
Q4 25
$294.0M
$602.0M
Q3 25
$-66.0M
$2.7B
Q2 25
$357.0M
$977.0M
Q1 25
$-18.0M
$154.0M
Q4 24
$246.0M
$694.0M
Q3 24
$-3.0M
$2.9B
Q2 24
$123.0M
$998.0M
Q1 24
$-324.0M
$661.0M
FCF Margin
AA
AA
EMR
EMR
Q4 25
8.5%
13.9%
Q3 25
-2.2%
54.9%
Q2 25
11.8%
21.5%
Q1 25
-0.5%
3.5%
Q4 24
7.1%
16.6%
Q3 24
-0.1%
63.1%
Q2 24
4.2%
22.8%
Q1 24
-12.5%
15.1%
Capex Intensity
AA
AA
EMR
EMR
Q4 25
7.0%
2.2%
Q3 25
5.0%
8.9%
Q2 25
4.3%
2.0%
Q1 25
2.8%
2.0%
Q4 24
4.8%
2.0%
Q3 24
5.0%
9.1%
Q2 24
5.6%
2.1%
Q1 24
3.9%
1.9%
Cash Conversion
AA
AA
EMR
EMR
Q4 25
2.52×
1.16×
Q3 25
0.37×
4.86×
Q2 25
2.98×
1.83×
Q1 25
0.14×
0.50×
Q4 24
2.05×
1.33×
Q3 24
1.59×
3.35×
Q2 24
14.35×
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AA
AA

Aluminum$2.5B72%
Third Party Sales$979.0M28%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons